Global Allergy Care Market Size By Type (Tablets, Sprays), By Application (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2023 to 2032

The Global Allergy Care Market was valued at USD 23.4 billion in 2023 and is projected to surpass USD 39.1 billion by 2031, growing at a CAGR of 6.7% during the forecast period from 2023 to 2031. The rising global prevalence of allergies, heightened environmental pollution, increased awareness of allergy diagnostics and treatments, and advances in immunotherapy have contributed significantly to the market's growth. With growing urbanization and changing lifestyles, allergy incidences are increasing, prompting more consumers and healthcare providers to seek effective prevention, diagnosis, and treatment solutions.

Drivers:

1. Increasing Prevalence of Allergic Conditions:

Rising incidences of allergic rhinitis, asthma, food allergies, and dermatitis are key factors fueling demand for allergy care products and services.

2. Advancements in Immunotherapy and Diagnostics:

Technological progress in allergen-specific immunotherapy (ASIT), skin prick testing, and in-vitro diagnostics enhances early detection and long-term treatment, supporting market expansion.

3. Rising Healthcare Expenditure and Awareness:

Government and non-profit initiatives to raise allergy awareness and the proliferation of online information channels are driving early diagnosis and consistent care-seeking behavior.

Restraints:

1. High Cost of Allergy Treatments:

Specialized treatment options like immunotherapy and biologics are often expensive, limiting access, particularly in lower-income regions.

2. Lack of Standardized Diagnostic Protocols:

Inconsistent testing methods across geographies create challenges in diagnosis accuracy, patient trust, and global adoption of allergy treatments.

Opportunity:

1. Growth in Emerging Economies:

Developing nations are experiencing a surge in allergy cases due to urbanization and pollution, creating demand for diagnostic services and over-the-counter (OTC) medications.

2. Development of Personalized Allergy Treatments:

Advancements in genomics and proteomics are enabling more tailored therapies, opening new revenue streams for biotech and pharmaceutical companies.

Market by System Type Insights:

Allergy Diagnostics accounted for the largest share in 2023, fueled by the rising demand for accurate testing methods such as ELISA, skin prick tests, and blood tests. However, Allergy Treatment, particularly via biologics and sublingual immunotherapy (SLIT), is projected to witness the fastest growth rate through 2031, owing to the increased focus on long-term allergy management.

Market by End-use Insights:

Hospitals and Clinics dominated the market in 2023 due to the widespread use of allergy testing and treatment services in structured medical environments. Homecare Settings are expected to grow rapidly during the forecast period, driven by the surge in self-care practices and availability of OTC medications and home test kits.

Market by Regional Insights:

North America led the global allergy care market in 2023, backed by strong healthcare infrastructure, high consumer awareness, and early adoption of novel therapies. Meanwhile, Asia-Pacific is forecast to record the highest CAGR, thanks to increased pollution levels, urbanization, and improving access to healthcare in countries such as China and India.

Competitive Scenario:

Key players in the Global Allergy Care Market include ALK-Abelló A/S, Stallergenes Greer, Thermo Fisher Scientific, Allergy Therapeutics, Sanofi, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., and HollisterStier Allergy. These companies are focused on strategic collaborations, product innovation, and expanding their presence in untapped markets.

Key Developments:

2023: Sanofi launched a biologic therapy targeting chronic spontaneous urticaria (CSU), enhancing its allergy care portfolio.

2024: ALK-Abelló expanded its sublingual immunotherapy (SLIT) tablet offerings in Asia-Pacific through local distribution partnerships.

2025: Thermo Fisher introduced an AI-enabled allergy diagnostics platform that delivers rapid, personalized test results.

Scope of Work – Global Allergy Care Market

FAQs:

1) What is the current market size of the Global Allergy Care Market?

The Global Allergy Care Market was valued at USD 23.4 billion in 2023.

2) What is the major growth driver of the Global Allergy Care Market?

The key growth driver is the increasing prevalence of allergies and the demand for advanced diagnostic and treatment solutions.

3) Which is the largest region during the forecast period in the Global Allergy Care Market?

North America is expected to remain the largest regional market due to its established healthcare infrastructure and high consumer awareness.

4) Which segment accounted for the largest market share in the Global Allergy Care Market?

The Allergy Diagnostics segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Allergy Care Market?

Key players include ALK-Abelló A/S, Stallergenes Greer, Thermo Fisher Scientific, Sanofi, and GlaxoSmithKline plc.